Shukra Pharmaceuticals Ltd.
| BSE: 524632 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE551C01028 |
| BSE 00:00 | 19 Aug | 185.55 |
-7.10 (-3.69%) |
OPEN
198.00 |
HIGH
198.00 |
LOW
183.40 |
| NSE 05:30 | 01 Jan | Shukra Pharmaceuticals Ltd |
| OPEN | 198.00 |
| PREVIOUS CLOSE | 192.65 |
| VOLUME | 1356 |
| 52-Week high | 209.90 |
| 52-Week low | 47.00 |
| P/E | 25.49 |
| Mkt Cap.(Rs cr) | 29 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Shukra Pharmaceuticals Ltd. (SHUKRAPHARMA) - Announcements
-
Shukra Pharmaceuticals Ltd Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On 25.08.2022.
18/08/2022 | bse |
Downlaod PDF -
Shukra Pharmaceuticals Ltd Financial Result For The Quarter Ended 30 June 2022
06/08/2022 | bse |
Downlaod PDF -
Shukra Pharmaceuticals Ltd Board Meeting Outcome for Meeting Of Board Of Directors Is Held On 06.08.2022.
06/08/2022 | bse |
Downlaod PDF -
Shukra Pharmaceuticals Ltd Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On 06.08.2022
23/07/2022 | bse |
Downlaod PDF -
Shukra Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09/07/2022 | bse |
Downlaod PDF -
Shukra Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended June 2022
09/07/2022 | bse
-
Shukra Pharmaceuticals Ltd Closure of Trading Window
28/06/2022 | bse |
Downlaod PDF -
Shukra Pharmaceuticals Ltd Clarification sought from Shukra Pharmaceuticals Ltd
10/06/2022 | bse
-
Shukra Pharmaceuticals Ltd Corporate Action-Board approves Dividend
28/05/2022 | bse |
Downlaod PDF -
Shukra Pharmaceuticals Ltd Financial Result For The Period Ended 31.03.2022
28/05/2022 | bse |
Downlaod PDF -
Shukra Pharmaceuticals Ltd Board Meeting Outcome for Meeting Of Board Of Directors Held On 28.05.2022
28/05/2022 | bse |
Downlaod PDF -
Shukra Pharmaceuticals Ltd Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On 28.05.2022
18/05/2022 | bse |
Downlaod PDF -
Shukra Pharmaceuticals Ltd Certificate Under Regulation 40 (9) Of The SEBI (LODR) Regulations 2015 For The Financial Year Ended
30/04/2022 | bse |
Downlaod PDF -
Shukra Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
30/04/2022 | bse |
Downlaod PDF -
Shukra Pharmaceuticals Ltd Compliance Certificate For The Year Ended 31St March 2022 Under Regulation 7 (3) Of SEBI (Listing Ob
21/04/2022 | bse |
Downlaod PDF -
Shukra Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended March 2022
20/04/2022 | bse
-
Shukra Pharmaceuticals Ltd Disclosure Under Regulation 32(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulati
13/04/2022 | bse |
Downlaod PDF -
Shukra Pharmaceuticals Ltd Closure of Trading Window
31/03/2022 | bse |
Downlaod PDF -
Shukra Pharmaceuticals Ltd Outcome Of Meeting Of Independent Director
26/03/2022 | bse |
Downlaod PDF -
Shukra Pharmaceuticals Ltd Intimation For Meeting Of Independent Director Of The Company To Be Held On 26.03.2022
20/03/2022 | bse |
Downlaod PDF
Quick Links for Shukra Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
